SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70He‐wei Jiang, Sheng‐ce Tao, Ze‐Guang Han et al.|Cellular and Molecular Immunology|2020Cited by 376
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in ChengduYongli Zheng, Dan Wang, Na Zhang et al.|Journal of Clinical Virology|2020Cited by 185
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patientsYang Li, Sheng‐ce Tao, Xionglin Fan et al.|Cell Reports|2021Cited by 183
Improvement of the stability of superelasticity and elastocaloric effect of a Ni-rich Ti-Ni alloy by precipitation and grain refinementHong Chen, Takashi Fukuda, Fei Xiao et al.|Scripta Materialia|2018Cited by 149
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infectionsQing Lei, Xionglin Fan, Yang Li et al.|Allergy|2020Cited by 138